These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 632598)

  • 1. Opsonic activity of guinea pig serum is reduced by in vivo administration of carcinogenic nitrosamines.
    Marom Z; Brade V; Colten HR
    J Immunol; 1978 Mar; 120(3):983-5. PubMed ID: 632598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of phagocytic activity and new appearance of a C4b (guinea pig) recognizing capability in peritoneal macrophages from Corynebacterium parvum and thioglycollate-stimulated mice.
    Wellek B; Kessel G; Loos M; Hahn H
    Monogr Allergy; 1977; 12():105-10. PubMed ID: 917013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat labile opsonin system to pneumococcus.
    Shin HS; Smith MR; Winkelstein J; Nicholson A
    Birth Defects Orig Artic Ser; 1975; 11(1):563-6. PubMed ID: 238689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement synthesis by guinea pig peritoneal macrophages: failure to detect chemical carcinogens.
    Kunke KS; Strunk RC
    J Natl Cancer Inst; 1981 Jan; 66(1):141-6. PubMed ID: 6935455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA; Falconer JS; Bashey A; Beck JS
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal and opsonic properties of C4-deficient guinea pig serum.
    Root RK; Ellman L; Frank MM
    J Immunol; 1972 Sep; 109(3):477-86. PubMed ID: 4403402
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phagocytosis promoting factor of rat serum independent of the complement system.
    McLain S; Siegel J; Molnar J; Allen C; Sabet T
    J Reticuloendothel Soc; 1976 Mar; 19(3):127-38. PubMed ID: 1263186
    [No Abstract]   [Full Text] [Related]  

  • 10. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
    Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.
    Leibovich SJ; Ross R
    Am J Pathol; 1975 Jan; 78(1):71-100. PubMed ID: 1109560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
    Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
    J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum opsonic activity in newborns and through the first year of life (author's transl)].
    Pedraz C; Lorente F; Pedraz MJ; Salazar V
    An Esp Pediatr; 1980 Jul; 13(7):577-82. PubMed ID: 7416648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis.
    Akalin HE; Laleli Y; Telatar H
    Q J Med; 1985 Aug; 56(220):431-7. PubMed ID: 3901076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in serum opsonic activity and complement levels in pneumococcal disease.
    Giebink GS; Dee TH; Kim Y; Quie PG
    Infect Immun; 1980 Sep; 29(3):1062-6. PubMed ID: 6903559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.